INR 2.01
(5.24%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | 6.08 Billion | 4.66 Billion | 11.4 Billion | 12.28 Billion | 7.93 Billion |
Cost of Revenue | - | 5.66 Billion | 5.15 Billion | 9.48 Billion | 10.48 Billion | 6.31 Billion |
Gross Profit | - | 417.65 Million | -495.57 Million | 1.92 Billion | 1.79 Billion | 1.62 Billion |
Operating Expenses | - | 643.91 Million | 618.7 Million | 1.15 Billion | 1.04 Billion | 727.57 Million |
Selling, General and Administrative Expenses | - | 4.99 Billion | 11.76 Million | 18.5 Million | 23.88 Million | 18.71 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 757.17 Million | 35.85 Million | 31.93 Million | 32.31 Million | 14.39 Million |
Cost and Expenses | - | 6.31 Billion | 5.77 Billion | 10.64 Billion | 11.52 Billion | 7.04 Billion |
Operating Income | - | -226.26 Thousand | -1.11 Million | 888.26 Thousand | 756.59 Million | 895.95 Million |
Interest Expense | - | 789.05 Million | 983.77 Million | 808.1 Million | 178.48 Million | 90.86 Million |
Income Tax Expense | - | 7.5 Billion | 1.06 Billion | 1.02 Billion | 78.15 Million | 313.35 Million |
Earnings before Tax | - | -6.97 Billion | -1.84 Billion | 110.23 Million | 636.28 Million | 902.42 Million |
Net Income | - | -6.97 Billion | -1.84 Billion | -57.31 Million | 615.3 Million | 583.35 Million |
Earnings Per Share Basic | - | -159.04 | -42.01 | -1.39 | 15.36 | 14.77 |
Earnings Per Share Diluted | - | -159.04 | -42.01 | -1.39 | 15.34 | 14.77 |
Weighted Average Shares Outstanding | - | 43.88 Million | 43.88 Million | 41.18 Million | 40.05 Million | 39.48 Million |
Weighted Average Shares Outstanding (Diluted) | - | 43.88 Million | 43.88 Million | 41.18 Million | 40.11 Million | 39.49 Million |
Gross Margin | - | 0.07 | -0.11 | 0.17 | 0.15 | 0.20 |
EBIT Margin | - | 0.31 | 0.19 | 0.23 | 0.10 | 0.15 |
Profit Margin | - | -1.15 | -0.40 | -0.01 | 0.05 | 0.07 |
EBITDA | - | -4.82 Billion | 793.33 Million | 2.57 Billion | 1.26 Billion | 901.8 Million |
Earnings Before Tax Margin | - | -0.00 | -0.00 | 0.00 | 0.06 | 0.11 |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | - | - | - | - | - | - |
Operating Income | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - |
Earnings before Tax | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Earnings Per Share Basic | - | - | - | - | - | - |
Earnings Per Share Diluted | - | - | - | - | - | - |
Weighted Average Shares Outstanding | - | - | - | - | - | - |
Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | - |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
MME
WOCKPHARMA
603390
HINDCOMPOS
RSMXF
QYBX